[2-fluoro-3-[2-(3-methoxyazetidin-1-yl)pyrimidin-5-yl]phenyl]methyl 3-amino-3-iminopropanoate
C18H20FN5O3 — CID 134819742
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-fluoro-3-[2-(3-methoxyazetidin-1-yl)pyrimidin-5-yl]phenyl]methyl 3-amino-3-iminopropanoate
[2-fluoro-3-[2-(3-methoxyazetidin-1-yl)pyrimidin-5-yl]phenyl]methyl 3-amino-3-iminopropanoate (PubChem CID 134819742) has the molecular formula C18H20FN5O3 and a molecular weight of 373.39 g/mol. Its IUPAC name is [2-fluoro-3-[2-(3-methoxyazetidin-1-yl)pyrimidin-5-yl]phenyl]methyl 3-amino-3-iminopropanoate.
Molecular Properties
| Compound Name | [2-fluoro-3-[2-(3-methoxyazetidin-1-yl)pyrimidin-5-yl]phenyl]methyl 3-amino-3-iminopropanoate |
|---|---|
| PubChem CID | 134819742 |
| Molecular Formula | C18H20FN5O3 |
| Molecular Weight | 373.39 g/mol |
| Exact Mass | 373.16 |
| IUPAC Name | [2-fluoro-3-[2-(3-methoxyazetidin-1-yl)pyrimidin-5-yl]phenyl]methyl 3-amino-3-iminopropanoate |
| SMILES | [H]/N=C(\N)CC(=O)OCc1cccc(-c2cnc(N3CC(OC)C3)nc2)c1F |
| InChI | InChI=1S/C18H20FN5O3/c1-26-13-8-24(9-13)18-22-6-12(7-23-18)14-4-2-3-11(17(14)19)10-27-16(25)5-15(20)21/h2-4,6-7,13H,5,8-10H2,1H3,(H3,20,21) |
| InChIKey | SNZAQEWXUCIJGW-UHFFFAOYSA-N |
| XLogP | 1.49 |
| TPSA | 114.42 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 373.39 |
| LogP ≤ 5 | 1.49 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134819742 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.